SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19.

Authors :: Anderson EM
Diorio C
Goodwin EC
McNerney KO
Weirick ME
Gouma S
Bolton MJ
Arevalo CP
Chase J
Hicks P
Manzoni TB
Baxter AE
Andrea KP
Burudpakdee C
Lee JH
Vella LA
Henrickson SE
Harris RM
Wherry EJ
Bates P
Bassiri H
Behrens EM
Teachey DT
Hensley SE
Source :: MedRxiv : the preprint server for health sciences [medRxiv] 2020 Aug 18. Date of Electronic Publication: 2020 Aug 18.
Publication Year :: 2020
Abstract: SARS-CoV-2 antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.

Full Text Access

Tools